{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:55Z","timestamp":1791407395321,"version":"4.3.3"},"reference-count":48,"publisher":"National Academy of Sciences","issue":"34","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2014,8,26]]},"abstract":"<jats:p>\n                    With the 2010s declared the Decade of Vaccines, and Millennium Development Goals 4 and 5 focused on reducing diseases that are potentially vaccine preventable, now is an exciting time for vaccines against poverty, that is, vaccines against diseases that disproportionately affect low- and middle-income countries (LMICs). The Global Burden of Disease Study 2010 has helped better understand which vaccines are most needed. In 2012, US$1.3 billion was spent on research and development for new vaccines for neglected infectious diseases. However, the majority of this went to three diseases: HIV\/AIDS, malaria, and tuberculosis, and not neglected diseases. Much of it went to basic research rather than development, with an ongoing decline in funding for product development partnerships. Further investment in vaccines against diarrheal diseases, hepatitis C, and group A\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    could lead to a major health impact in LMICs, along with vaccines to prevent sepsis, particularly among mothers and neonates. The Advanced Market Commitment strategy of the Global Alliance for Vaccines and Immunisation (GAVI) Alliance is helping to implement vaccines against rotavirus and pneumococcus in LMICs, and the roll out of the MenAfriVac meningococcal A vaccine in the African Meningitis Belt represents a paradigm shift in vaccines against poverty: the development of a vaccine primarily targeted at LMICs. Global health vaccine institutes and increasing capacity of vaccine manufacturers in emerging economies are helping drive forward new vaccines for LMICs. Above all, partnership is needed between those developing and manufacturing LMIC vaccines and the scientists, health care professionals, and policy makers in LMICs where such vaccines will be implemented.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1400473111","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T02:18:04Z","timestamp":1408414684000},"page":"12307-12312","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":55,"title":["Vaccines against poverty"],"prefix":"10.1073","volume":"111","author":[{"given":"Calman A.","family":"MacLennan","sequence":"first","affiliation":[{"name":"Novartis Vaccines Institute for Global Health, 53100 Siena, Italy; and"},{"name":"Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, Institute of Biomedical Research, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Saul","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Institute for Global Health, 53100 Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2014,8,18]]},"reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00290-09"},{"key":"e_1_3_2_2_2","first-page":"15","article-title":"The value of vaccination","volume":"6","author":"Bloom DE","year":"2005","unstructured":"DE Bloom, D Canning, M Weston, The value of vaccination. World Econ 6, 15\u201339 (2005).","journal-title":"World Econ"},{"key":"e_1_3_2_3_2","first-page":"1367","article-title":"Global routine vaccination coverage, 2009","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"; Centers for Disease Control and Prevention (CDC), Global routine vaccination coverage, 2009. MMWR Morb Mortal Wkly Rep 59, 1367\u20131371 (2010).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_4_2","unstructured":"GAVI Alliance (2014) Saving children's lives and protecting people's health by increasing access to immunisation in poor countries. Available at http:\/\/www.gavialliance.org\/. Accessed February 12 2014."},{"key":"e_1_3_2_5_2","unstructured":"United Nations Development Programme (2014) The Millenium development goals. Available at http:\/\/www.undp.org\/content\/undp\/en\/home\/mdgoverview\/. Accessed February 12 2014."},{"key":"e_1_3_2_6_2","unstructured":"World Health Organization (2011) Mr Bill Gates Co-chair of the Bill & Melinda Gates Foundation Speech to the sixty-fourth World Health Assembly. Available at http:\/\/www.who.int\/mediacentre\/events\/2011\/wha64\/bill_gates_speech_20110517\/en\/index.html. Accessed February 12 2014."},{"key":"e_1_3_2_7_2","unstructured":"World Health Organization (2013) Global vaccine action plan 2011-2020. Available at http:\/\/www.dovcollaboration.org\/wp-content\/uploads\/2013\/03\/GlobalVaccineActionPlan_interactive.pdf. Accessed March 29 2014."},{"key":"e_1_3_2_8_2","unstructured":"Institute for Health Metrics and Evaluation (2010) Global burden of diseases injuries and risk factors study 2010. Available at http:\/\/www.healthmetricsandevaluation.org\/gbd\/research\/project\/global-burden-diseases-injuries-and-risk-factors-study-2010. Accessed February 12 2014."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61719-X"},{"key":"e_1_3_2_12_2","unstructured":"PATH (2014) Malaria vaccine initiative. Available at http:\/\/www.malariavaccine.org\/. Accessed February 12 2014."},{"key":"e_1_3_2_13_2","unstructured":"Global HIV Vaccine Enterprise (2014) Global HIV Vaccine Enterprise. Available at http:\/\/www.vaccineenterprise.org\/. Accessed February 12 2014."},{"key":"e_1_3_2_14_2","unstructured":"AERAS. (2014) AERAS advancing tuberculosis vaccines for the world. Available at http:\/\/www.aeras.org. Accessed February 12 2014."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102287"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908492"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07930"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0097"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064142"},{"key":"e_1_3_2_20_2","unstructured":"World Health Organization (2012) Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation. Available at http:\/\/www.who.int\/neglected_diseases\/NTD_RoadMap_2012_Fullversion.pdf. Accessed February 12 2014."},{"key":"e_1_3_2_21_2","unstructured":"Uniting to Combat NTDs (2012) The London declaration on neglected tropical diseases. Available at http:\/\/www.unitingtocombatntds.org\/downloads\/press\/london_declaration_on_ntds.pdf. Accessed February 12 2014."},{"key":"e_1_3_2_22_2","unstructured":"World Health Organization (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases. Available at www.who.int\/iris\/bitstream\/10665\/77950\/1\/9789241564540_eng.pdf. Accessed February 12 2014."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040275"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70028-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70072-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.13.27"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328356ffeb"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70241-X"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-3611-1.50007-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60766-6"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0906.030020"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.03.014"},{"key":"e_1_3_2_33_2","unstructured":"Policy Cures G-FINDER (2013) Neglected disease research and development: The public divide. Available at http:\/\/www.policycures.org\/downloads\/GF_report13_all_web.pdf. Accessed February 12 2014."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/26.5.1090"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-9-32"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60560-1"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60844-2"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1052"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1207-1361"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60406-6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/11207130-000000000-00000"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60687-9"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003812"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.060"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.05.004"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2494"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035616"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.068"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1400473111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T23:29:31Z","timestamp":1649806171000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1400473111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,18]]},"references-count":48,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2014,8,26]]}},"alternative-id":["10.1073\/pnas.1400473111"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1400473111","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,18]]},"assertion":[{"value":"2014-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}